• Shows
  • Schedule
  • Support Us
  • Volunteer
  • The Team
  • How to submit music
  • Contact
  • Vision
DONATE
SUBSCRIBE
NEWSLETTER
SCHEDULE
PODCASTS

AstraZeneca

From Pharma to Table; Australia’s Vaccine Odyssey

Think Business Futures In this, our glorious return to the airwaves, we ask; What does the…

Think: Business Futures

NSW’s rollout from the eyes of those administering vaccines

As New South Wales active COVID cases continue to increase in the latest outbreak, vaccination rates…

Health, science & tech

The Week That Was – 20th August 2021

This week Anthony Dockrill speaks with breakfast host Willy Russo to discuss the government’s role in…

2SER Breakfast

The Week That Was – 6th August 2021

As the city lockdown continues, Anthony Dockrill joined Willy Russo on 2Ser Breakfast to give a…

2SER Breakfast

AstraZeneca Vaccine Needed to End Lockdowns

As the lockdown continues, it’s clear that getting vaccinated is critical to protecting health and returning…

The Daily

Quashing Vaccine Concerns; Why No Australian Has to Worry About the Sa...

Image:unsplash; courtesy of CDC The safety of any vaccine will always stir debate, especially in the…

Current affairs & analysis

The Pill: Clotting Explained

Image:Shutterstock: areeya_ann In the UK, 79 rare cases of blood clots caused by the AstraZeneca vaccine…

Current affairs & analysis

Women advised to delay mammogram screenings after receiving the COVID ...

Despite delays, Australia’s vaccine rollout is finally underway. Phase 2a is set to begin in a…

The Daily

Concerns Around the AstraZeneca Vaccine

Several countries in Europe have decided to resume the use of the AstraZeneca vaccine after Europe’s…

The Daily

ABOUT US
  • Vision
  • The Team
  • How to submit music
  • Hire Our Studios
  • Policies
  • Contact
SUPPORT
  • Support Us
  • Volunteer
  • Sponsorship
PROGRAMS
  • Schedule
  • Shows
  • Topics

2ser on Instagram 2ser on Facebook 2ser on Twitter

UTS Logo
Macquarie University

Audio hosting by MyRadio.Click
Copyright 2016 - 2SER - ABN 90 001 684 564 - All rights reserved